Liquidia (LQDA) Earnings Date & Reports

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

LQDA is expected to report earnings to rise 50.29% to 78 cents per share on August 06

Q2'26

Est.

$0.78

Q1'26

Beat

by $0.15

Q4'25

Missed

by $0.04

Q3'25

Beat

by $0.37

Q2'25

Missed

by $0.07

The last earnings report on May 11 showed earnings per share of 51 cents, beating the estimate of 37 cents. With 598.11K shares outstanding, the current market capitalization sits at 6.71B.

View a ticker or compare two or three

Compare

LQDA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LQDA